There's a new DNA test for babies that can check for 193 genetic diseases
Forget counting fingers and toes — new parents may soon be able to analyze their baby's genes.
MIT Technology Review reported Wednesday that the health information company Sema4 has developed a DNA test that screens babies for almost 200 genetic diseases. The test, which costs $649, is intended to expand on existing screeners recommended by the U.S. government, which only flag roughly 30 genetic disorders. With the ability to identify a greater number of abnormalities in their baby's first days — including ones that otherwise may not yield accurate diagnoses for years — parents can "get a better understanding of the health of your child," said Eric Schadt, the CEO of Sema4.
The test uses saliva procured from a baby's cheek to screen for problematic genetic alterations, as well as potential reactions to a range of medications usually given to young children, the Review says. Sema4's test has not yet been approved for coverage by insurance companies, which means dutiful parents will have to pick up the tab on their own for the time being.
The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
The potential for expanded health knowledge isn't without its consequences. Some of the genetic abnormalities Sema4 is designed to detect may not cause symptoms for years, the Review notes, and "sometimes a child can carry a mutation but never develop the corresponding disease" at all. That means that overanxious parents may subject their children to expensive or intrusive medical procedures based on Sema4's results that may not actually be necessary. Laura Hercher, a genetics professor at Sarah Lawrence College, cautioned: "For many families, this is the kind of thing that can open up a can of worms where it doesn't end up necessarily benefiting the parent or child."
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Kelly O'Meara Morales is a staff writer at The Week. He graduated from Sarah Lawrence College and studied Middle Eastern history and nonfiction writing amongst other esoteric subjects. When not compulsively checking Twitter, he writes and records music, subsists on tacos, and watches basketball.
-
Political cartoons for January 4Cartoons Sunday's political cartoons include a resolution to learn a new language, and new names in Hades and on battleships
-
The ultimate films of 2025 by genreThe Week Recommends From comedies to thrillers, documentaries to animations, 2025 featured some unforgettable film moments
-
Political cartoons for January 3Cartoons Saturday's political cartoons include citizen journalists, self-reflective AI, and Donald Trump's transparency
-
TikTok secures deal to remain in USSpeed Read ByteDance will form a US version of the popular video-sharing platform
-
Unemployment rate ticks up amid fall job lossesSpeed Read Data released by the Commerce Department indicates ‘one of the weakest American labor markets in years’
-
US mints final penny after 232-year runSpeed Read Production of the one-cent coin has ended
-
Warner Bros. explores sale amid Paramount bidsSpeed Read The media giant, home to HBO and DC Studios, has received interest from multiple buying parties
-
Gold tops $4K per ounce, signaling financial uneaseSpeed Read Investors are worried about President Donald Trump’s trade war
-
Electronic Arts to go private in record $55B dealspeed read The video game giant is behind ‘The Sims’ and ‘Madden NFL’
-
New York court tosses Trump's $500M fraud fineSpeed Read A divided appeals court threw out a hefty penalty against President Trump for fraudulently inflating his wealth
-
Trump said to seek government stake in IntelSpeed Read The president and Intel CEO Lip-Bu Tan reportedly discussed the proposal at a recent meeting
